Hospital Universitario Puerta de Hierro -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Tyrosine kinase inhibitor dose reduction during the management ofaccelerated phase chronic myeloid leukemia

    Leukemia Research